Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shulman

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Archives of Neurology|March 14, 2000
Levodopa toxicity in Parkinson disease: reality or myth? Reality--practice patterns should changeL M Shulman
European Journal of Neurology|October 29, 2000
How to succeed in using dopamine agonists in Parkinson's diseaseL M Shulman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
Viewpoint: reductionism and the study of neurodegenerative disordersL M Shulman
Health Progress (Saint Louis, Mo.)|January 5, 2002
The prescription for long-term care. Improving the care of chronic conditions will have the single greatest effect on the long-term care crisisL M Shulman
Virus Research|July 29, 2008
Unraveling the puzzle of human anellovirus infections by comparison with avian infections with the chicken anemia virusI Davidson, L M Shulman
Annual Review of Virology|July 19, 2017
Viruses with Circular Single-Stranded DNA Genomes Are Everywhere!L M Shulman, I Davidson
Neurology|October 1, 1995
Post-traumatic movement disordersW J Weiner, L M Shulman
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Dopamine inhibits mammalian photoreceptor Na+,K+-ATPase activity via a selective effect on the alpha3 isozymeL M Shulman, D A Fox
Seminars in Neurology|June 1, 1995
Paroxysmal movement disordersL M Shulman, W J Weiner
Neurology|October 1, 1996
Worth of neurologistsW J Weiner, L M Shulman
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Archives of Neurology|March 14, 2000
Levodopa toxicity in Parkinson disease: reality or myth? Reality--practice patterns should changeL M Shulman
European Journal of Neurology|October 29, 2000
How to succeed in using dopamine agonists in Parkinson's diseaseL M Shulman
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1997
Viewpoint: reductionism and the study of neurodegenerative disordersL M Shulman
Health Progress (Saint Louis, Mo.)|January 5, 2002
The prescription for long-term care. Improving the care of chronic conditions will have the single greatest effect on the long-term care crisisL M Shulman
Virus Research|July 29, 2008
Unraveling the puzzle of human anellovirus infections by comparison with avian infections with the chicken anemia virusI Davidson, L M Shulman
Annual Review of Virology|July 19, 2017
Viruses with Circular Single-Stranded DNA Genomes Are Everywhere!L M Shulman, I Davidson
Neurology|October 1, 1995
Post-traumatic movement disordersW J Weiner, L M Shulman
Proceedings of the National Academy of Sciences of the United States of America|July 23, 1996
Dopamine inhibits mammalian photoreceptor Na+,K+-ATPase activity via a selective effect on the alpha3 isozymeL M Shulman, D A Fox
Seminars in Neurology|June 1, 1995
Paroxysmal movement disordersL M Shulman, W J Weiner
Neurology|October 1, 1996
Worth of neurologistsW J Weiner, L M Shulman
Pageof 8